Verapamil prevents cyclosporine-induced hypertension by modulating endothelin a receptor expression in rat kidney membranes

• Published in: Transplantation proceedings Vol. 30; no. 5; pp. 2028 - 2029
• Main Authors: Giovannini, L, Migliori, M, Taccola, D, Panichi, V, Andreini, B, De Pietro, S, Filippi, C, Del Ry, S, Andreassi, M.G, Colombo, M.G, Biagini, A, Giannessi, D, Palla, R
• Format: Journal Article Conference Proceeding
• Language: English
• Published: New York, NY Elsevier Inc 01.08.1998; Elsevier Science
• Subjects: Animals; Biological and medical sciences; Blood Pressure - drug effects; Cell Membrane - metabolism; Cyclosporine - toxicity; Drug toxicity and drugs side effects treatment; Endothelin-1 - metabolism; Gene Expression Regulation - drug effects; Hypertension - chemically induced; Hypertension - prevention & control; Iodine Radioisotopes; Kidney - drug effects; Kidney - metabolism; Male; Medical sciences; Pharmacology. Drug treatments; Radioligand Assay; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin - biosynthesis; Receptors, Endothelin - genetics; Toxicity: urogenital system; Verapamil - pharmacology; Human; Hypertension; Vasodilator agent; Rat; Toxicity; Rodentia; Calcium antagonist; Vasoconstriction; Cardiovascular disease; Endothelin 1; Binding site; Kidney; Prevention; Vertebrata; Mammalia; Animal; Distribution; Aralkylamine; Verapamil; Ciclosporin; Immunosuppressive agent; Mechanism of action; Biological receptor
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/S0041-1345(98)00520-X